Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenfu injection for severe COVID-19 pneumonia
ChiCTR2000030043Phase 4Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Feb 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of shenfu injection in coronavirus disease 2019 (COVID-19) and pneumonia (2 arms), sponsored by Peking University Third Hospital. Primary endpoints: Pneumonia severity index and Incidence of new organ dysfunction. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
shenfu injection
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on ChiCTR2000030043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030043.